A survey of transfusion practices in pediatric hematopoietic stem cell transplant patients

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 2, 2013, Pages

  Bercovitz, Rachel S ^a,b,c   Quinones, Ralph R ^a,c  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

hematopoietic stem cell transplant; pediatrics; platelet transfusion; red blood cell transfusion; transfusion threshold

Indexed keywords

ANEMIA; ANTICOAGULANT THERAPY; BLEEDING; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL PRACTICE; CONTINUOUS HEMODIALYSIS; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATURIA; HEMOGLOBINOPATHY; HUMAN; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; ONCOLOGY; PEDIATRICS; PRIORITY JOURNAL; REVIEW; SEPSIS; SICKLE CELL ANEMIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE;

BLOOD TRANSFUSION; CHILD; ERYTHROCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PLATELET TRANSFUSION;

EID: 84874453429     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182707ae5     Document Type: Review

References (15)

1. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356:1609-1619.
2. Hebert PC. Transfusion requirements in critical care (TRICC): a multicentre, randomized, controlled clinical study. Transfusion Requirements in Critical Care Investigators and the Canadian Critical care Trials Group. Br J Anaesth. 1998; 81(suppl 1):25-33.
3. Wandt H, Frank M, Ehninger G, et al. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood. 1998;91:3601-3606.
4. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med. 1997;337:1870-1875.
5. Stanworth SJ, Hyde C, Heddle N, et al. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. 2004;CD004269.
6. Josephson CD, Su LL, Christensen RD, et al. Platelet transfusion tractices among neonatologists in the United States and Canada: results of a survey. Pediatrics. 2009;123:278-285.
7. Laverdiere C, Gauvin F, Hebert PC, et al. Survey on transfusion practices of pediatric intensivists. Pediatr Crit Care Med. 2002;3:335-340.
8. Nathan M, Selwood K. The use of blood products in paediatric oncology units in the UK. Paediatr Nurs. 2006;18:14-17.
9. Wong EC, Perez-Albuerne E, Moscow JA, et al. Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists. Pediatr Blood Cancer. 2005;44:119-127.
10. Harkensee C, Vasdev N, Gennery AR, et al. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation-a systematic review and evidence-based guidance for clinical management. Br J Haematol. 2008;142:717-731.
11. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1519-1538.
12. Avvisati G, Tirindelli MC, Annibali O. Thrombocytopenia and hemorrhagic risk in cancer patients. Crit Rev Oncol Hematol. 2003;48:S13-S16.
13. Holler E, Kolb HJ, Greinix H, et al. Bleeding events and mortality in SCT patients: a retrospective study of hemato-poietic SCT patients with organ dysfunctions due to severe sepsis or GVHD. Bone Marrow Transplant. 2008;43: 491-497.
14. Edwards PJ, Roberts I, Clarke MJ, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. Chichester, UK: John Wiley & Sons Ltd; 2009.
15. Josephson CD, Glynn SA, Kleinman SH, et al. A multi-disciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium. Transfusion. 2011;51:828-841.